1. Cancer Statistics, 2021
2. People’s Republic of China. Opinions on the reform of the review and approval system to encourage innovation in drugs and medical devices. 2017. http://www.gov.cn/zhengce/2017-10/08/content_5230105.htm
3. Jie He JL Ma J Qin S Jiang Z . Chinese Society of Clinical Oncology common malignant neoplasm treatment guidelines consolidated book 2021. People's Medical Publishing House, 2021.
4. Ministry of Finance, General Administration of Customs, State Taxation Administration, et al. Notice of value added tax policy on anti-cancer drugs. 2018. http://www.gov.cn/zhengce/zhengceku/2018-12/31/content_5439687.htm
5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. 2021 https://www.nccn.org/guidelines/category_1